Article Text

Download PDFPDF

Gemfibrozil reduced the risk for stroke in men with coronary heart disease and low concentrations of high-density lipoprotein cholesterol
Free

Statistics from Altmetric.com


 
 QUESTION: In men with coronary artery disease and low concentrations of high-density lipoprotein (HDL) cholesterol, is gemfibrozil effective for preventing stroke?

Design

Randomised {allocation concealed*}, blinded {patients, outcome assessors, and study personnel},* placebo-controlled trial with mean 5.1 years of follow up (Veterans Affairs HDL Cholesterol Intervention Trial [VA-HIT]).

Setting

20 Veterans Affairs medical centres in the USA.

Patients

2531 men who were < 74 years of age (mean age 64 y) and had a confirmed diagnosis of coronary artery disease, an HDL cholesterol level < 1.03 mmol/l, a low-density lipoprotein cholesterol level < 3.6 mmol/l, and a triglyceride level < 3.39 mmol/l. Follow up was complete.

Intervention

1264 men were allocated …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.